You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daclizumab

Showing 26 - 50 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transplant; Failure, Kidney Trial in Miami (Alemtuzumab, Daclizumab, Thymoglobulin)

Completed
Has Results
  • Transplant; Failure, Kidney
  • Miami, Florida
    University of Miami Miller School of Medicine
Nov 5, 2017

Diabetes Type 1 Trial run by the NIDDK (Islet Transplantation)

Completed
  • Diabetes Mellitus Type 1
  • Islet Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 19, 2021

IBD, Crohn Disease, Ulcerative Colitis Trial in Spain (Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab)

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
  • Oviedo, Asturias, Spain
  • +19 more
Mar 15, 2022

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM

Unknown status
  • Multiple Sclerosis
  • Buenos Aires, Argentina
  • +3 more
Aug 7, 2019

Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Uveitis
  • Daclizumab
  • Bethesda, Maryland
    National Eye Institute (NEI)
Jun 30, 2017

HIV Trial run by the NIAID (Daclizumab)

Completed
  • HIV Infections
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Uveitis
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Non-infectious Intermediate and Posterior Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Non-infectious Intermediate and Posterior Uveitis
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Multiple Sclerosis, Relapsing-Remitting Trial run by the NINDS (Daclizumab)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

GVHD, Steroid Refractory GVHD, Acute GVH Disease Trial in Gainesville, Columbus, San Antonio (Infliximab and Basiliximab)

Terminated
Has Results
  • Graft Versus Host Disease
  • +2 more
  • Infliximab and Basiliximab
  • Gainesville, Florida
  • +2 more
Apr 3, 2019

End Stage Renal Disease Trial in Chicago (Expanded Tregs)

Completed
  • End Stage Renal Disease
  • Expanded Tregs
  • Chicago, Illinois
    Northwestern University Comprehensive Transplant Center
Oct 4, 2019

Uveitis Trial run by the NEI (Daclizumab (Zenapax))

Completed
  • Uveitis
  • Daclizumab (Zenapax)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

GVHD Trial in Iowa City (daclizumab, infliximab)

Completed
  • Graft vs Host Disease
  • daclizumab, infliximab
  • Iowa City, Iowa
    University of Iowa Hospitals
Feb 16, 2017

Chronic Graft-versus-host Disease Trial in Germany (PredEver)

Completed
  • Chronic Graft-versus-host Disease
  • Hamburg, Germany
  • +5 more
Apr 1, 2020

Type 1 Diabetes Trial in Canada, United States (Islet transplantation, Antithymocyte Globulin, Daclizumab or Basiliximab)

Completed
  • Type 1 Diabetes Mellitus
  • Islet transplantation
  • +4 more
  • San Francisco, California
  • +9 more
Oct 18, 2017

Anterior Uveitis, Arthritis, Juvenile Idiopathic, Iritis Trial run by the NEI (Daclizumab)

Completed
Has Results
  • Anterior Uveitis
  • +3 more
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 27, 2017

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (drug, other, biological)

Completed
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • Centennial, Colorado
  • +18 more
Jan 23, 2017

GVHD Trial in United States (Daclizumab, methylprednisolone, Placebo)

Completed
  • Graft Versus Host Disease
  • Daclizumab
  • +2 more
  • Boston, Massachusetts
  • +7 more
Jan 19, 2017

Chemo, Tumor, Ovarian Cancer Trial in Philadelphia (OCDC)

Completed
  • Chemotherapy
  • +2 more
  • OCDC
  • Philadelphia, Pennsylvania
    Ovarian Cancer Research Center
Jun 8, 2018

Age-Related Macular Degeneration, Choroidal Neovascularization Trial run by the NEI (Intravenous Daclizumab, Intravenous

Completed
Has Results
  • Age-Related Macular Degeneration
  • Choroidal Neovascularization
  • Intravenous Daclizumab
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 28, 2016

GVHD Trial in Worldwide (Begelomab, Conventional Second-line Treatment)

Terminated
Has Results
  • Graft vs Host Disease
  • Begelomab
  • Conventional Second-line Treatment
  • Duarte, California
  • +26 more
Jan 20, 2020

Heart Transplantation Trial in Spain (Daclizumab, Mycophenolate mofetil, Silrolimus)

Completed
  • Heart Transplantation
  • Daclizumab
  • +2 more
  • Barcelona, Spain
  • +13 more
Nov 1, 2016

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Chicago (NA17.A2 Peptide Vaccine, Recombinant MAGE-3.1 Antigen, Recombinant

Terminated
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • NA17.A2 Peptide Vaccine
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Aug 31, 2016

Diabetes, Insulin-Dependent Trial in Worldwide (Islet Transplantation, Sirolimus, Tacrolimus)

Completed
Has Results
  • Diabetes Mellitus, Insulin-Dependent
  • Islet Transplantation
  • +7 more
  • Miami, Florida
  • +8 more
Feb 6, 2017

Kidney Diseases, Kidney Transplantation, Kidney Transplant Trial in United States (Daclizumab, Mycophenolate mofetil (MMF),

Completed
Has Results
  • Kidney Diseases
  • +4 more
  • Daclizumab
  • +6 more
  • Birmingham, Alabama
  • +11 more
Oct 19, 2016